Upper Tract Tumors
Olaparib is effective for recurrent urothelial carcinoma with BRCA2 pathogenic germline mutation: first report on olaparib response in recurrent UC.
December 1, 2020
Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a pooled analysis.
November 30, 2020
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC).
November 25, 2020
Robot-Assisted Surgery for Upper Tract Urothelial Carcinoma.
November 24, 2020
Complete Pathological Response to Neoadjuvant Pembrolizumab in a Patient With Chemoresistant Upper Urinary Tract Urothelial Carcinoma: A Case Report.
November 17, 2020
B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival.
November 13, 2020
The effect of tumor location on overall survival for pT2-4 bladder and upper tract urothelial carcinoma following radical surgery.
November 5, 2020
Immune checkpoint inhibition in upper tract urothelial carcinoma.
November 3, 2020
Diagnostic accuracy of photodynamic diagnosis for upper urinary tract urothelial carcinoma: A systematic review and meta-analysis.
October 29, 2020